Erkes DA - Search Results

1

Intratumoral Infection with Murine Cytomegalovirus Synergizes with PD-L1 Blockade to Clear Melanoma Lesions and Induce Long-term Immunity.

Erkes DA, Xu G, Daskalakis C, Zurbach KA, Wilski NA, Moghbeli T, Hill AB, Snyder CM. Erkes DA, et al. Mol Ther. 2016 Aug;24(8):1444-55. doi: 10.1038/mt.2016.121. Epub 2016 Jun 10. Mol Ther. 2016. PMID: 27434584 Free PMC article.

2

Cytomegalovirus and immunotherapy: opportunistic pathogen, novel target for cancer and a promising vaccine vector.

Quinn M, Erkes DA, Snyder CM. Quinn M, et al. Among authors: erkes da. Immunotherapy. 2016 Feb;8(2):211-21. doi: 10.2217/imt.15.110. Epub 2016 Jan 20. Immunotherapy. 2016. PMID: 26786895 Free PMC article. Review.

3

Virus-Specific CD8⁺ T Cells Infiltrate Melanoma Lesions and Retain Function Independently of PD-1 Expression.

Erkes DA, Smith CJ, Wilski NA, Caldeira-Dantas S, Mohgbeli T, Snyder CM. Erkes DA, et al. J Immunol. 2017 Apr 1;198(7):2979-2988. doi: 10.4049/jimmunol.1601064. Epub 2017 Feb 15. J Immunol. 2017. PMID: 28202614 Free PMC article.

4

Intratumoral infection by CMV may change the tumor environment by directly interacting with tumor-associated macrophages to promote cancer immunity.

Erkes DA, Wilski NA, Snyder CM. Erkes DA, et al. Hum Vaccin Immunother. 2017 Aug 3;13(8):1778-1785. doi: 10.1080/21645515.2017.1331795. Epub 2017 Jun 12. Hum Vaccin Immunother. 2017. PMID: 28604162 Free PMC article. Review.

5

Activation of CD8⁺ T Cells Contributes to Antitumor Effects of CDK4/6 Inhibitors plus MEK Inhibitors.

Teh JLF, Erkes DA, Cheng PF, Tiago M, Wilski NA, Field CO, Chervoneva I, Levesque MP, Xu X, Dummer R, Aplin AE. Teh JLF, et al. Among authors: erkes da. Cancer Immunol Res. 2020 Sep;8(9):1114-1121. doi: 10.1158/2326-6066.CIR-19-0743. Epub 2020 Jul 13. Cancer Immunol Res. 2020. PMID: 32661093 Free PMC article.

6

Mechanisms of Antiviral Cytotoxic CD4 T Cell Differentiation.

Knudson CJ, Férez M, Alves-Peixoto P, Erkes DA, Melo-Silva CR, Tang L, Snyder CM, Sigal LJ. Knudson CJ, et al. Among authors: erkes da. J Virol. 2021 Sep 9;95(19):e0056621. doi: 10.1128/JVI.00566-21. Epub 2021 Jul 14. J Virol. 2021. PMID: 34260270 Free PMC article.

7

BET Inhibition Modifies Melanoma Infiltrating T Cells and Enhances Response to PD-L1 Blockade.

Nikbakht N, Tiago M, Erkes DA, Chervoneva I, Aplin AE. Nikbakht N, et al. Among authors: erkes da. J Invest Dermatol. 2019 Jul;139(7):1612-1615. doi: 10.1016/j.jid.2018.12.024. Epub 2019 Jan 28. J Invest Dermatol. 2019. PMID: 30703359 Free PMC article. No abstract available.

8

FOXD3 Regulates VISTA Expression in Melanoma.

Rosenbaum SR, Knecht M, Mollaee M, Zhong Z, Erkes DA, McCue PA, Chervoneva I, Berger AC, Lo JA, Fisher DE, Gershenwald JE, Davies MA, Purwin TJ, Aplin AE. Rosenbaum SR, et al. Among authors: erkes da. Cell Rep. 2020 Jan 14;30(2):510-524.e6. doi: 10.1016/j.celrep.2019.12.036. Cell Rep. 2020. PMID: 31940493 Free PMC article.

9

PLX3397 inhibits the accumulation of intra-tumoral macrophages and improves bromodomain and extra-terminal inhibitor efficacy in melanoma.

Erkes DA, Rosenbaum SR, Field CO, Chervoneva I, Villanueva J, Aplin AE. Erkes DA, et al. Pigment Cell Melanoma Res. 2020 Mar;33(2):372-377. doi: 10.1111/pcmr.12845. Epub 2019 Dec 11. Pigment Cell Melanoma Res. 2020. PMID: 31696640 Free PMC article.

10

The next-generation BET inhibitor, PLX51107, delays melanoma growth in a CD8-mediated manner.

Erkes DA, Field CO, Capparelli C, Tiago M, Purwin TJ, Chervoneva I, Berger AC, Hartsough EJ, Villanueva J, Aplin AE. Erkes DA, et al. Pigment Cell Melanoma Res. 2019 Sep;32(5):687-696. doi: 10.1111/pcmr.12788. Epub 2019 May 20. Pigment Cell Melanoma Res. 2019. PMID: 31063649 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page